Quantro Therapeutics

QUANTRO Therapeutics GmbH is a privately funded research company dedicated to the discovery and development of novel therapies to interfere with pathogenic transcriptional programs in cancer and other diseases. QUANTRO will combine and develop innovative technologies in the fields of functional genetics and transcriptomics to create an unprecedented pipeline for cancer drug discovery, transforming the precision and scope of cell-based compound screening.